Contact Us
Pay Invoice
Follow Us!
Latest Blogs
- Global IVD Growth: Stability, Shifting Markets, and the Road to 2030 February 11, 2026
- Cell and Gene Therapy at a Turning Point January 30, 2026
- Sepsis Gap & Home Testing Growth: Interview with Kalorama Information’s Daniel Granderson January 9, 2026
- What Is the Size of the IVD Market in 2025? September 8, 2025
- Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain June 24, 2025
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Global IVD Growth: Stability, Shifting Markets, and the Road to 2030
The global in vitro diagnostic market continues to expand in both size and strategic importance. According to the 18th edition of Kalorama Information’s The Worldwide Market for In Vitro Diagnostic (IVD) Tests, the industry now represents a $113 billion global market, up from just under $100 billion only five years ago. That growth alone signals […]
Cell and Gene Therapy at a Turning Point
It is an exciting and dynamic time to be involved in the cell and gene therapy industry. Kalorama Information estimates the global cell and gene therapy market at approximately $16 billion in 2025, spanning key therapeutic areas such as oncology, neurology, musculoskeletal, dermatology, cardiology, and others. Kalorama projects double‑digit global market growth through 2030. “Kalorama […]
Sepsis Gap & Home Testing Growth: Interview with Kalorama Information’s Daniel Granderson
This special blog post is reprinted with permission from the Eye on IVD newsletter and features an interview with Kalorama Senior Editor Daniel Granderson, offering insights into the IVD market outlook for 2026. Before we shift attention to J.P. Morgan Healthcare this year, let’s get a sense of where we are in in vitro diagnostics […]
What Is the Size of the IVD Market in 2025?
According to Kalorama Information, the IVD market is $113 billion. As Kalorama releases its 18th edition of the Worldwide Market for In Vitro Diagnostic Tests, the IVD market is experiencing moderate-level growth. These are the main factors that will shape markets right now in IVD. Some will drive growth and others will limit growth. Some […]
Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain
Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain Arlington, VA — June 2025 — A new survey of 195 diagnostic imaging and clinical lab professionals reveals that tariff policy uncertainty is already changing how providers plan staffing, purchasing, and vendor relationships. The latest Beyond the Bench […]
4 Fascinating Facts About Cancer Diagnostics
Kalorama Information is proud to introduce our recent report, The World Market for Cancer Diagnostics, 2024-2029. This comprehensive analysis provides an authoritative overview of the global cancer in vitro diagnostics (IVD) market, highlighting key trends, market sizing, and growth opportunities. In this report, you’ll find an in-depth review of the cancer IVD market, enriched with expert […]
Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge
The global veterinary diagnostics market is set to experience a 6% compound annual growth rate (CAGR) over the next five years. This growth is driven by low barriers to market entry, a competitive landscape that allows for substantial advancements in various segments, a continued surge in pet ownership, and growing concerns over the emergence of […]
Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies
The lab diagnostics industry is evolving at an unprecedented pace, driven by shifting regulations, decentralized testing growth, and rapid advancements in molecular and point-of-care technologies. Companies relying on outdated anecdotal insights or outdated data risk falling behind in a competitive landscape where market shifts and customer demands evolve in real time. “Custom Competitive Intelligence (CI) […]
The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market
Pharmacodiagnostics is swiftly emerging as a vital player in the global cancer diagnostics market, which soared to nearly $10 billion in revenue in 2024, according to Kalorama Information’s recent report, The World Market for Cancer Diagnostics, 2024-2029. This dynamic sub-segment is experiencing rapid growth, fueled by the increasing affordability of next-generation sequencing (NGS), which offers profound […]
IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing
This blog draws on insights from the Kalorama Information report, In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029. For further details, please visit the report’s product page HERE. Personalized medicine, also known as precision medicine, is revolutionizing the healthcare landscape. This innovative approach tailors medical treatment to the individual characteristics of […]